News

05/09/23

Opin.AI Breaks Down Barriers in Clinical Trial Participation

17/01/23

2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher

07/12/22

Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher

07/11/22

Big data could cure cancer

21/10/22

Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates

30/09/22

Improving clinical trials with AI. Michelle Gallaher, Opyl.

28/09/22

Opyl tips revenue growth from partnership with Consentic and its newly launched screening services

16/09/22

Opyl appoints news chairman as it eyes international growth

08/09/22

ANDHealth Summit 2022 – Technology as a Therapy

01/09/22

Opyl prepares to launch Opin into the global $4.7 billion clinical trial recruitment market

29/07/22

ASX Quarterlies: Tech powers ahead in strong finish to reporting week

07/07/22

Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit